Articles

Gary Palmer, MD, JD, MBA, MPH points out the value for oncologists, industry, and the payers to know where oncology is going in order to stay current of the trends and its future.

Value Propositions - October 2016

Value Propositions, Value Peer-spectives

October 2016, Vol 7, No 9

ASCO Names the 14 Oncology Practices Participating in the 2016 Quality Training Program, Highlighting Significant Improvements in Care Delivery

By Laura Morgan

Oncology Practice

October 2016, Vol 7, No 9

Biology, Genetics Guide Diagnosis and Treatment of Thyroid Cancers

By Charles Bankhead

Personalized Medicine, Thyroid Cancer

October 2016, Vol 7, No 9

Recent advances in the management of thyroid cancer have evolved directly from improved knowledge of the underlying genetics and molecular biology, an understanding that will continue to improve in the future, according to a recent review.

Is Direct-to-Consumer Advertising for Cancer Drugs Beneficial to Patients?

By Jessica Miller

Health Policy, Policies & Guidelines

October 2016, Vol 7, No 9

DCIS Score Not Cost-Effective in Selecting Patients for Adjuvant Radiation

By Wayne Kuznar

Value in Oncology

October 2016, Vol 7, No 9

Hematologic Cancers Among the Most Costly Malignancies to Treat

By Alice Goodman

Hematologic Cancers, Value in Oncology

October 2016, Vol 7, No 9